Adding pirfenidone to mycophenolate mofetil shows no significant improvement in lung function compared with mycophenolate ...
Many doctors agree with the Food and Drug Administration’s recent decision to remove the black box warnings on at least some ...
During a live event, Kathryn E. Beckermann, MD, PhD, and participants discussed whether risk stratification factors into the ...
With only two products on the market, Inner Balance is offering an alternative to long-standing treatment models in hormone ...
Radiation has been a staple of breast cancer treatment for decades, but a new study is casting doubt on whether it is ...
Based on the positive global Phase III MANEUVER study, the National Medical Products Administration (NMPA) has granted the ...
Chronic sleep deprivation acts as a systemic stressor, elevating risks for cardiovascular disease and metabolic dysregulation while impairing cognitive function.
BOOG 13-08 shows skipping sentinel lymph node biopsy in patients 50+ with early-stage, hormone receptor–positive, ...
Guselkumab has received approval for moderate to severe plaque psoriasis in children and adolescents from the age of 6 years who are candidates for systemic therapy.1 ...
The FDA granted accelerated approval to Lunsumio VELO for adults with relapsed/refractory follicular lymphoma after two or ...
ME/CFS is a neurological condition characterized by malaise. Diagnosis requires ruling out other systemic illnesses.
Lunsumio Velo is supplied as a ready-to-use, preservative-free solution in single-dose vials containing 5mg/0.5mL and 45mg/mL.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback